nouveau test , detecte aussi les bacteries enkystées
Posté : 09 juin 2015 18:01
NEW LYME TEST THAT CAN DETECT DORMANT CYSTIC FORMS AS WELL AS ACTIVE SPIROCHETES
Welcome to LymeSpot revised
After the success of EliSpot, a method used to detect infections of Borrelia on a cellular level, we decided to introduce an updated version to our laboratory that gives us an even greater insight into the diagnosis and appropriate treatment of the disease: the LymeSpot Revised.
We can now determine whether we are dealing with an active or latent Borrelia infection, as well as evaluating whether the issue lies with a patient’s infection, inflammation or autoimmune processes.
While EliSpot is based on the production of γ-interferon, LymeSpot Revised also detects cytokine IL-2 and uses the ‘traffic light’ principle to indicate the appropriate course of action to take with each patient.
For more information about the LymeSpot Revised test, please click below to download our information brochure.
Please visit www.infectolab.de for more information, or contact us directly if you have any other questions or would like to find out more about our services and research projects. For more information about the treatment of tick-borne diseases please visit www.b-c-a.de.
E: service@infectolab.de
T: + 49 (0) 821 4550740
http://www.infectolab.de/#15
Welcome to LymeSpot revised
After the success of EliSpot, a method used to detect infections of Borrelia on a cellular level, we decided to introduce an updated version to our laboratory that gives us an even greater insight into the diagnosis and appropriate treatment of the disease: the LymeSpot Revised.
We can now determine whether we are dealing with an active or latent Borrelia infection, as well as evaluating whether the issue lies with a patient’s infection, inflammation or autoimmune processes.
While EliSpot is based on the production of γ-interferon, LymeSpot Revised also detects cytokine IL-2 and uses the ‘traffic light’ principle to indicate the appropriate course of action to take with each patient.
For more information about the LymeSpot Revised test, please click below to download our information brochure.
Please visit www.infectolab.de for more information, or contact us directly if you have any other questions or would like to find out more about our services and research projects. For more information about the treatment of tick-borne diseases please visit www.b-c-a.de.
E: service@infectolab.de
T: + 49 (0) 821 4550740
http://www.infectolab.de/#15